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Background: Humans spend more than one-fourth of their life sleeping, and sleep quality 
has been significantly linked to health. However, the objective examination of ambulatory 
sleep quality remains a challenge, since sleep is a state of unconsciousness, which limits 
the reliability of self-reports. Therefore, a non-invasive, continuous, and objective method 
for the recording and analysis of naturalistic sleep is required.
objective: Portable sleep recording devices provide a suitable solution for the ambu-
latory analysis of sleep quality. In this study, the performance of two activity-based 
sleep monitors (Actiwatch and MTN-210) and a single-channel electroencephalography 
(EEG)-based sleep monitor (SleepScope) were compared in order to examine their 
reliability for the assessment of sleep quality.
Methods: Twenty healthy adults were recruited for this study. First, data from daily activity 
recorded by Actiwatch and MTN-210 were compared to determine whether MTN-210, 
a more affordable device, could yield data similar to Actiwatch, the de facto standard. In 
addition, sleep detection ability was examined using data obtained by polysomnography 
as reference. One simple analysis included comparing the sleep/wake detection ability 
of Actiwatch, MTN-210, and SleepScope. Furthermore, the fidelity of sleep stage deter-
mination was examined using SleepScope in finer time resolution.
Results: The results indicate that MTN-210 demonstrates an activity pattern comparable to 
that of Actiwatch, although their sensitivity preferences were not identical. Moreover, MTN-
210 provides assessment of sleep duration comparable to that of the wrist-worn Actiwatch 
when MTN-210 was attached to the body. SleepScope featured superior overall sleep 
detection performance among the three methods tested. Furthermore, SleepScope was 
able to provide information regarding sleep architecture, although systemic bias was found.
conclusion: The present results suggest that single-channel EEG-based sleep monitors 
are the superior option for the examination of naturalistic sleep. The current results pave 
a possible future use for reliable portable sleep assessment methods in an ambulatory 
rather than a laboratory setting.
Keywords: portable sleep monitors, activity recorders, single channel eeg, polysomnography, sleep estimation
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InTRoDUcTIon
Sleep is a physiological phenomenon that occupies more than 
one-fourth of the human lifespan. Accordingly, sleep disorders 
have been linked to various medical conditions, including car-
diovascular disease, diabetes, and dementia (1–3). Such sleep 
disorders include not only frequently observed sleep apnea but 
also circadian rhythm disorders and insomnia. However, the 
underlying function of sleep remains uncertain partially due 
to the heterogenic level of sleep within each sleep session (4). 
Furthermore, it has been stressed that sleep quality and quantity 
vary significantly on a nightly basis, depending on the environ-
ment or workload on the preceding day (5–7).
The current gold standard for sleep examination is polysom-
nography (PSG), in which patients are required to spend one 
night in a specialized room. During PSG examination, sleep 
features are recorded by various sensors, including multichannel 
electroencephalography (EEG) (8). This system requires well-
trained technicians in addition to a highly sophisticated EEG 
system that allows the recording of subtle electrical activity in 
the human body. However, the likelihood of capturing rare sleep-
related events in a single examination session is low. Accordingly, 
in a clinical setting, patients often report sleep symptoms that 
only occur once in a few nights.
In addition to problems inherent to PSG, a recent study has 
indicated the importance of naturalistic sleep examination in 
daily life, instead of in a sleep examination room. A further study 
reported that even multiple sleep assessments in a PSG exami-
nation room might not accurately represent naturalistic sleep 
quality (9). In conjunction with the well-established first-night 
effect (10), these studies indicate that single-night sleep assess-
ment methods might not adequately represent the nature of sleep 
in daily life. Therefore, a convenient method for the assessment 
of sleep quality in daily life might provide an ideal solution to 
this problem.
Several different devices capable of portable sleep assessment 
are currently available. The majorities of these devices utilize 
body movements or abridged EEG signals as an indicator of sleep 
status.
Activity-based sleep monitors, including the frequently 
used Actiwatch (Actiwatch2, Philips Respironics, Amsterdam, 
Netherlands), are also used as daytime activity monitors, because 
they are small devices that do not hinder activities of daily life. 
Because of this advantage, such devices are often preferred to 
detect unpredicted sleep fall. Devices of this kind have under-
gone significant improvement in the past few decades to improve 
and expand their utility (11–14). In the current era of wearable 
devices, activity sensors have become increasingly economical 
and new devices have been developed (15, 16), including the 
MTN-210 (Kissei Comtec, Nagano, Japan). Both research level 
and consumer level devices have become attractive options for 
the study of naturalistic sleep status.
In sharp contrast to the widely used activity-based sleep 
monitors, EEG-based sleep monitors have a relatively short 
history of use (17, 18). Since EEG electrodes are attached to the 
head during recording, this typically limits their use to nighttime. 
However, sleep architecture is only directly observable through 
EEG activity; therefore, EEG-based monitors can potentially be 
used for the assessment of naturalistic sleep quality. In addition, 
the simpler mechanism of EEG is preferred for the recording 
of naturalistic sleep, since untrained subjects will be required 
to use this method in their home. Accordingly, single channel 
EEG has recently attracted attention (19–21), although its reli-
ability has not been compared to that of activity-based sleep 
recorders. To address this question, an EEG recorder Sleep Scope 
(Sleepwell, Osaka, Japan) was used in the present study, whose 
prototype device has been previously validated in patients with 
sleep disorders (22).
Since portable devices are more economical and less complex 
than PSG, and assessing naturalistic sleep is of great impor-
tance, it will be of interest for both clinicians and patients if the 
physiological validity and reliability of these portable devices 
are established. However, the reliability of not only newly devel-
oped devices but also currently used devices remains unclear. 
Therefore, the present study aimed to address this question by 
conducting cross-modal comparisons of the sleep monitors 
previously discussed.
MATeRIAlS AnD MeThoDS
participants
Twenty-two healthy volunteers participated in this study. Due 
to an Actiwatch malfunction and a data download failure in an 
MTN-210, two participants were excluded from analysis. The total 
participants therefore included 11 males and 9 females (age range 
19–24 years; mean age 20.70 ± 0.39). Eighteen participants were 
undergraduate students, and two were graduate school students. 
None of them were obese (body mass index: 20.68 ± 0.44 kg/m2) 
or pregnant. The Mini International Neuropsychiatric Interview 
(23) was used to screen past medical history, and an additional 
interview by experienced psychiatrists found that none of the 
participants had a record of psychiatric or sleep disorders.
All study procedures were approved by the Ethics Committee 
of Shiga University of Medical Science.
Written informed consent was obtained from all participants, 
and the study was performed in accordance with the Declaration 
of Helsinki.
Actigraphy Analysis
Actiwatch and MTN-210 were used for activity-based sleep 
recordings. Participants were required to wear Actiwatch devices 
around the non-dominant wrist. To compare the inter-device 
differences in activity data, one MTN-210 was clipped to the 
Actiwatch wristband to ensure these two devices were exposed 
to the same range of movement. Moreover, participants were 
required to wear another MTN-210 on the front side of the trunk, 
by clipping it to waist belt or to the edge of the trousers/pants. 
Recording started at 8:00 a.m. on day 1, and PSG recording was 
performed on the night of day 7. Actigraphy recordings were 
stopped at 8:00 a.m. in the morning after PSG recording was 
completed. All devices were configured to record activity every 
2 min. A 2-min epoch was used, since this time window is often 
used to save memory space when long-term activity logging is 
required. Since perfect synchronization was required between 
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PSG and the activity monitors for epoch-by-epoch evaluation, 
all devices were synchronized to one timeserver through the 
Internet. Furthermore, synchronization was visually confirmed 
by tracing activity bursts intentionally evoked prior to PSG 
recording. By using these collection protocols, 5040 2-min 
epochs were collected before and during PSG examination. 
Data were extracted from MTN-210 devices through an NFC 
interface (PaSoRi, RC-S380, Sony Corporation, Japan) using 
SleepSign Act software (Kissei Comtec, Nagano, Japan). For 
sleep/wake detection from MTN-210 data, default settings in 
SleepSign Act were used, in which sleep detection followed the 
previously reported algorithm (24). Data were extracted from 
Actiwatch devices using Actiware 6.0.1 (Philips Respironics, 
Amsterdam, Netherlands) through a designated device cradle. 
To determine the method-dependent changes in sleep/wake 
detection, we used three different Actiware thresholds; low (20), 
medium (40), and high (80). This software scores epochs by 
applying these thresholds to the weighted-moving-average of 
activity data. This algorithm has been validated to PSG data (25).
SleepScope Analysis
SleepScope (SS) is a single channel portable EEG device from 
SleepWell (Osaka, Japan). SS recordings were conducted on the 
last night concurrent to PSG recording. Both the method and 
analysis of the SS recordings are described in detail elsewhere 
(26). But briefly, one SS electrode was placed in the middle of 
forehead and the other electrode on left mastoid. In addition, the 
data obtained by SS were forwarded to cloud services (SEAS-G, 
Sleepwell, Osaka, Japan), in which spectral analysis of the EEG 
data was performed for every 30-s epoch, and they are classified 
into five sleep stages: wake, REM, stage 1, stage 2, and stage 3. 
Stage information was provided with the time stamp, and the EEG 
trace is also available for download. These timing data allowed us 
to synchronize SS results with other data set used in this study. 
This service is approved by Japanese Medical Device Certification 
(225ADBZX00020000).
Sensitivity Analysis of Activity Sensors
To investigate the differential sensitivities of MTN-210 and 
Actiwatch, the devices were exposed to the same activity by plac-
ing them on an iron bar that was loosely attached to the ridge of 
a shaker plate (BR-13UM, TAITEC, Japan). The shaker was set at 
five discrete speeds (0, 50, 75, 100, and 150 rpm) for 5 min, and 
the corresponding count recordings were compared.
pSg Recordings
Polysomnography recordings were performed using an Alice-5 
system (Respironics Inc., Murrysville, PA, USA) with the follow-
ing set of measurements: four-electrode scalp-encephalography 
(C3–A2, C4–A1, O1–A2, and O2–A1), two-electrode electrooc-
ulography (placed near edge of the eyes), electrocardiography, 
and electromyography, in addition to sensors for the detection 
of oral/nasal airflow, and chest/abdominal movements. PSG 
data were recorded online by Alice Sleepware (version 2.8, 
Respironics Inc., Murrysville, PA, USA). An experienced PSG 
specialist, who was blind to participants’ conditions, scored sleep 
stages visually.
In order to match the 30-s PSG epochs to the 2-min actigraphy 
epochs, the most frequent sleep stage scored by PSG within the 
corresponding 2-min actigraphy epoch was designated as the 
representative sleep stage of the 2-min epoch.
Statistical Analysis
A paired Student’s t-test was performed where appropriate. 
One-way analysis of variance (ANOVA) was used to compute 
significance between more than three groups, and a post hoc test 
with Tukey correction was applied to test individual comparisons. 
All statistical analyses were performed using PRISM-6 software 
(GraphPad, La Jolla, CA, USA). Data are presented as mean ± SE, 
unless otherwise stated.
ReSUlTS
Difference and preference 
of Activity Monitors
First, the differences between the two activity recorders were 
examined by comparing the wrist data from Actiwatch (ACT-W) 
and MTN-210 (MTN-W). In addition, the effects of recording 
site were assessed by placing another MTN-210 on the body 
trunk (MTN-B). Figure 1 displays the representative 7-day acti-
graphs from one participant and the corresponding analysis. We 
conducted following analysis using all 7-day data.
Good agreement was found between MTN-W and ACT-W 
data (Spearman’s rank correlation: r =  0.97 ±  0.00, P <  0.01, 
n = 20, Figure 1D), although Actiwatch counts were two orders 
of magnitude higher than the MTN-W counts (max counts: 
MTN-W, 61.65 ± 0.17; ACT-W, 7337.05 ± 892.51; n = 20), sug-
gesting a considerable difference in the sensitivity resolution of 
each device.
By activity sensor sensitivity analysis, it was demonstrated 
that the activity count recordings were not linearly correlated 
to the shaker speed, and that the ranges of ultra-sensitivity 
were identified [75–100 rpm (roughly corresponding to 10–60 
counts/2  min) for MTN-210 and over 100  rpm (roughly cor-
responding to 1000 counts/2 min) for Actiwatch (Figure 2C)].
Intriguingly, real-life activity data distributions were extremely 
low compared to these superior sensitivity ranges. For example, 
61.85  ±  1.65% of activity was lower than 10  counts/2  min 
for MTN-210, and 97.06 ±  0.28% of activity was lower than 
1000 counts/2 min for Actiwatch (Figures 2A,B).
On comparing the placements, a strong correlation was iden-
tified between activity data from MTN-W and MTN-B, despite 
sporadic higher counts owing to hand activity from the MTN-W 
placement site (Spearman’s rank correlation: r =  0.87 ±  0.03, 
P < 0.01, n = 20, Figure 1E). These data indicated that a resem-
bling activity pattern could be obtained independent of the 
placement on the body.
comparison of portable Monitors 
as Sleep Recorders
Next, the sleep/wake detection abilities of activity-based and 
single-channel EEG-based sleep monitors were compared. Using 
the software provided by the manufacturers, sleep parameters 
FIgURe 1 | Representative actigraphs from Actiwatch, MTn-210 on the wrist, MTn-210 on the body, and corresponding analysis. Actigraphs of 7 days 
prior to and during PSG are shown, where the days and time when PSG was conducted are shown on the X-axis, and the activity counts for every 2 min (A–c) are 
shown on the Y-axis. Correlation of the activity between MTN-W and Actiwatch is compared by scatter plot (D) or MTN-B and MTN-W (e). MTN-B, MTN-210 on 
the body; MTN-W, MTN-210 on the wrist; PSG, polysomnography.
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were assessed using the 2-min epoch data. For the analysis of 
Actiwatch data, wake detection thresholds were set to 80, 40, or 
20, and these conditions were referred to as Act80, Act40, and 
Act20, respectively.
The average duration of recordings was 477.70 ±  3.79  min, 
and the average sleep duration as assessed by PSG was 
419.10 ±  10.88  min (range: 286–462  min), suggesting that all 
participants slept for an adequate time during the analysis.
Sleep durations estimated by SS, Act80, Act40, Act20, MTN-B, 
and MTN-W were 408.30 ± 11.99, 438.00 ± 5.76, 406.10 ± 8.32, 
366.50 ± 11.33, 353.70 ± 16.85, and 260.10 ± 17.65 min, respec-
tively (Figure 3A). These data indicated that Act20, MTN-B, and 
MTN-W estimated significantly shorter sleep durations than 
PSG (P < 0.05 for Act20, P < 0.01 for MTN-B, and P < 0.0001 
for MTN-W, one-way ANOVA after Dunnett’s correction). This 
finding is also supported by Bland–Altman analysis, where SS, 
Act80, and Act40 featured bias less than 20 min, whereas others 
demonstrated larger bias (Figure 4; Table 1). Correlation analy-
sis further demonstrated that SS estimations featured a strong 
correlation (r = 0.73, P < 0.01), while Act80 featured a modest 
correlation with PSG (r = 0.55, P < 0.05).
Sleep latency as defined by PSG was 6.20  ±  0.43  min. 
Sleep latency estimations by SS, Act80, Act40, Act20, MTN-
B, and MTN-W were 21.1 ±  7.50, 8.50 ±  3.09, 12.60 ±  3.54, 
15.00 ± 3.67, 21.50 ± 4.86, and 29.40 ± 5.77 min, respectively 
(Figure  3B). MTN-B and MTN-W estimated a significantly 
longer sleep latency (P <  0.05 for MTN-B and P <  0.01 for 
MTN-W). Compared to the short duration of sleep latency, 
bias related to these methods was relatively large (Table 1). All 
methods had longer bias than the actual length of sleep latency 
(6.20 min) except for Act80, demonstrating that these methods 
can overestimate sleep latency by double. In addition, none of 
FIgURe 2 | Sensitivity preferences and differences between MTn-W and Actiwatch. Distributions are shown by frequency on the Y-axis, and corresponding 
activity strength is shown on the X-axis (A,B). Sensitivity preferences were compared. The shaker speed is indicated on the X-axis, and the corresponding counts 
are displayed on the Y-axis (c). MTN-W, MTN-210 on the wrist.
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the sleep latency estimations demonstrated a correlation with 
PSG results.
Similarly, wake after sleep onset (WASO) was examined 
in the present study (Figure  3C). PSG results indicated that 
WASO was 53.00 ±  10.98  min, while SS, Act80, Act40, Act20, 
MTN-B, and MTN-W estimated WASO at 49.60  ±  10.48, 
28.40 ±  5.23, 55.50 ±  8.13, 91.20 ±  11.46, 93.90 ±  14.65, and 
177.50 ± 20.42 min, respectively. This analysis found that estima-
tions by Act20 and MTN-B were significantly longer than addi-
tional methods (P < 0.05 for Act20 and P < 0.0001 for MTN-W). 
Bland–Altman analysis support that SS was suitable for WASO 
estimation, as it had small bias (−3.4 min) with strong correlation 
(r = 0.64, P < 0.01) followed by Act80 with bias less than half an 
hour (−24.6 min) and moderate correlation (r = 0.53, P < 0.05).
The difference in estimated sleep parameters suggested that 
sleep/wake delineation differed significantly depending on the 
choice of device or threshold. To examine the ability of each 
method to delineate sleep/wake epochs, the sensitivity and 
specificity of each method was assessed. The analysis identified 
superior performance using the SS method, as its sensitivity 
was 92.43 ± 1.83% and specificity was 69.69 ± 4.95% (Table 2). 
Similar sensitivity (93.00 ± 0.81%) was found in Act80, but this 
high sensitivity was achieved at the cost of the lowest specificity 
(15.87 ± 5.71%) of all the techniques analyzed. This is confirmed 
by receiver–operator curve analysis, as area under curve (AUC) 
was largest in SS (AUC for SS, Act80, Act40, Act20, MTN-B, and 
MTN-W were: 0.64, 0.15, 0.26, 0.38, 0.44, and 0.46, respectively).
Since activity-based methods demonstrated inferior sensitiv-
ity and specificity, the sleep stage-dependent accuracy of each 
technique was compared to explore the characteristics that 
compromised their estimations. With regard to sleep stage-based 
analysis, we found that estimations were poor at the awake and 
FIgURe 3 | Sleep parameters were compared among the devices/
conditions. Sleep duration (A), sleep latency (B) and wake after sleep 
onset (c) estimations by all the devices/conditions are compared. Conditions 
are displayed on the X-axis, and parameter values on the Y-axis. White box 
shows data from PSG as a reference. Asterisks show levels of significance: 
*P < 0.05, **P < 0.01, ***P < 0.001. PSG, polysomnography.
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N1 stage compared to other sleep stages using the same method 
(Figure 5). These data demonstrated relatively poor performance 
of activity-based sleep monitors largely due to the misjudgment 
of N1 and wake stage epochs.
Sleep Architecture Analysis 
by Single channel eeg
Since the analysis indicated that SS results were most closely 
linked to PSG, the results were examined using additional data 
(30-s epoch data). These data demonstrated that the total sleep 
time estimated using SS did not significantly differ from PSG 
analysis (408.56 ±  10.22 vs. 403.88 ±  10.54  min for PSG and 
SS, respectively, P =  0.244 two-tailed paired Student’s t-test). 
Moreover, the correlation coefficient was strong (correlation 
coefficient: 0.93, P <  0.01), and Bland–Altman analysis con-
firmed the comparable assessment between PSG and SS, with 
negligible bias (bias ± SD was −4.68 ± 18.35, where 95% limits of 
agreement were −40.66 to 31.29). Upon combining these data, 
SS appeared to represent a good substitute for PSG.
Next, the ability of SS to estimate sleep stage duration 
was examined. The comparison of non-REM sleep Stage 1 
(NS-1) lengths indicated that this estimation was compa-
rable to that of PSG results (PSG: 44.60 ±  6.17  min vs. SS: 
43.52 ± 3.90 min, P = 0.834 two-tailed paired Student’s t-test). 
However, the comparison of additional stages found differential 
results, since longer Stage 2 (PSG: 217.91 ± 11.40 min vs. SS: 
238.03 ± 9.94 min, P < 0.01 two-tailed paired Student’s t-test), 
shorter Stage 3 (PSG: 69.96 ± 4.63 min vs. SS: 32.59 ± 6.62 min, 
P < 0.001 two-tailed paired Student’s t-test), and longer REM 
durations (PSG: 75.26 ±  6.18  min vs. SS: 89.74 ±  5.70  min, 
P < 0.01 two-tailed paired Student’s t-test) were observed using 
SS analysis. Sleep stage-wise agreement between PSG and SS 
were assessed by calculating percentage agreement of detected 
30-s epochs (Table  3). This analysis showed good agreement 
(the Kappa statistics; k = 0.64 ± 0.03) between PSG and SS, with 
poorest performance for Stage 1 (30.56 ± 2.64% agreement) fol-
lowed by awake detection (56.04 ± 4.49% agreement), whereas 
comparable performance for Stage 3, Stage 2, and REM. Despite 
a significant difference in the estimation of stage duration, the 
correlation between estimations and their corresponding PSG 
data indicated a moderate to strong correlation (correlation 
coefficient and P value for N1 were 0.57 and 0.0028, N2: 0.851 
and <0.0001, N3: 0.56 and 0.0036, and REM: 0.75 and <0.0001, 
respectively). Bland–Altman analysis also indicated negligible 
bias for N1 assessment (−1.08 ±  23.86, −47.84 to 45.68) but 
systematic bias toward a decrease in N3 (−37.37  ±  26.21, 
−88.74 to 13.99) and an increase in SS for N2 (20.13 ± 28.09, 
−34.93 to 75.18) and REM (14.48 ±  19.89, −24.51 to 53.47). 
On combining these data, it was suggested that the systematic 
bias contributed to the differences in group-wise comparison, 
although the correlations were consistently strong, regardless 
of sleep stage.
DIScUSSIon
In this cross-modal comparison study, the EEG-based sleep 
monitor “SleepScope” was found to be superior to activity-based 
sleep monitors in accurately detecting sleep status.
As the representative activity-based sleep monitor, the widely 
used Actiwatch was compared against the newly developed 
MTN-210 device. Recently, multiple comparisons between 
wearable activity monitors drew attention, particularly in two 
categories; those of updated version of research level device or 
those of affordable consumer level devices (16, 27–29).
In terms of sleep detection, Ferguson and colleagues tested 
7 consumer level activity recorders over 48 h of activity record-
ings in 21 healthy participants (15). They reported strong 
FIgURe 4 | Bland–Altman plot analysis of sleep duration estimations. Bland–Altman plot for sleep duration estimations by all the methods. Horizontal solid 
lines represent the means of the differences, and dashed lines represent 95% limits of agreement.
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FIgURe 5 | comparisons of epochs ratio, correctly assigned to sleep 
or awake. Bar plots represent percentage of epochs correctly assigned to 
either sleep or awake are shown. Sleep/wake detection made by portable 
devices are examined in each PSG-defined sleep stages. In awake, % of 
epochs correctly detected by portable devices as awake are shown. In other 
sleep stages, % of epochs correctly detected by portable devices as sleep 
are shown.
TABle 2 | cross-modal comparison of sensitivities and specificities.
SS Act80 Act40 Act20 MTn-B MTn-W
Sensitivity 92.43 ± 1.83 93.00 ± 0.81 87.27 ± 1.30 80.00 ± 1.95 77.71 ± 3.27 59.50 ± 3.71
Specificity 69.69 ± 4.95 15.87 ± 3.04 30.23 ± 4.00 47.34 ± 5.52 56.65 ± 6.29 76.83 ± 5.71
The sensitivities and specificities of sleep epoch detection are compared among the methods. SS performance was superior among the methods analyzed.
SS, SleepScope.
TABle 1 | Sleep parameters were compared among the devices/
conditions.
Bland–Altman correlation analysis
Bias (95% limits of 
agreement)
pearson  
r
P (two-tailed)
(A) Sleep duration
SS −10.8 (−85.18 ± 63.58) 0.7286 0.0003 ***
Act80 18.9 (−60.55 ± 98.35) 0.5534 0.0114 *
Act40 −13 (−105.2 ± 79.24) 0.4246 0.062 ns
Act20 −52.6 (−159.5 ± 54.3) 0.3975 0.0826 ns
MTN-B −65.4 (−214 ± 83.21) 0.3131 0.1789 ns
MTN-W −159 (−316.2 ± −1.842) 0.2821 0.2281 ns
(B) Sleep latency
SS 14.9 (−49.54 ± 79.34) 0.3597 0.1193 ns
Act80 2.3 (−24.33 ± 28.93) 0.1851 0.4347 ns
Act40 8.5 (−63.3 ± 80.3) 0.2434 0.3011 ns
Act20 8.8 (−22.62 ± 40.22) 0.2518 0.2841 ns
MTN-B 15.3 (−26.87 ± 57.47) 0.1626 0.4935 ns
MTN-W 23.2 (−27.25 ± 73.65) 0.06577 0.7829 ns
(c) WASo
SS −3.4 (−83.33 ± 76.53) 0.6397 0.0024 **
Act80 −24.6 (−106.6 ± 57.38) 0.5259 0.0172 *
Act40 2.5 (−93.77 ± 98.77) 0.3694 0.1089 ns
Act20 38.2 (−76.5 ± 152.9) 0.3204 0.1685 ns
MTN-B 40.9 (−96.4 ± 178.2) 0.2793 0.2331 ns
MTN-W 124.5 (−59.14 ± 308.1) 0.2198 0.3517 ns
Bland–Altman analysis and correlation analysis were conducted against estimations by 
various methods. Panel (A) shows result for sleep duration, (B) for sleep latency, and 
(C) for WASO.
WASO, wake after sleep onset.
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validity of these devices for sleep duration estimation (bias: 
15.9–44.2  min, Pearson’s r: 0.82–0.92). Similarly, Rosenberger 
and colleagues conducted an examination using nine wearable 
activity monitors and concluded that they could be used as sleep 
length monitors at certain level of accuracy (mean error from 
8.1 to 16.9%) (16).
However, these studies left several points to be addressed. 
First, these studies did not examine the specification of activity 
sensors that is necessary to isolate the mechanical potential of 
these devices. Second, these studies assessed gross sleep duration 
rather than sleep/wake detection accuracy and were therefore 
inadequate for the assessment of epoch-by-epoch accuracy of 
these devices. The other factor is that these studies employed 
“research level” activity or portable reduced-channel EEG moni-
tors as reference, and therefore sleep might not be as accurately 
assessed as by PSG.
With respect to the mechanical aspect of activity sensors, 
both MTN-210 and Actiwatch featured a sensitivity preference 
range for activity above 75 rpm, a range that does not encompass 
the majority of sleep-related activities. This finding raised the 
possibility that future devices with a suitable detection range for 
sleep-related activity might be capable of more accurate sleep/
wake delineation.
Direct comparison of activity counts between MTN-210 and 
Actiwatch demonstrated unpredicted results. Even with regard to 
differences in sensitivity and resolution, non-parametric testing 
confirmed that the strength of activity recorded by the MTN-210 
and Actiwatch were closely related. Taken together, these findings 
suggest that MTN-210 could be used as an alternative life activity 
recorder in place of the Actiwatch.
In studies using “research level” activity monitors, it is indi-
cated that activity-based methods feature limited performance, 
wherein good sleep detection sensitivity can only be achieved 
if specificity is compromised. For example, one of the largest 
study conducted by Kushida, in which 100 sleep disorder 
patients had participated, it was reported that sleep time, sleep 
efficiency, and even number of awakenings were successfully 
estimated by activity monitors (25). Similar findings were 
replicated in recent study in different populations. One study 
targeting 12 preschool children reported good performance of 
activity monitors in estimation of sleep latency, total sleep time, 
and sleep efficiency (30). However, even correlation analysis 
showed good performances in these studies; it has been noted 
that sleep detecting specificity is poor (31). Low sleep detecting 
TABle 3 | Sleep stage-wise agreement between SS and pSg.
pSg
Awake n1 n2 n3 ReM
SS Awake 56.05 ± 4.49 15.59 ± 2.26 3.23 ± 0.95 5.55 ± 2.74 10.4 ± 3.66
N1 14.97 + 2.39 30.56 ± 2.64 6.1 ± 1.22 7.82 ± 3.6 7.59 ± 1.85
N2 17.17 ± 3.15 43.55 ± 3.85 69.22 ± 2.64 15.85 ± 4.48 17.61 ± 5.17
N3 6.98 ± 2.03 3.31 ± 1.93 17.32 ± 1.9 69.97 ± 8.58 2.57 ± 1.57
REM 4.83 ± 1.29 6.98 ± 1.76 4.13 ± 1.29 0.81 ± 0.58 61.82 ± 7.32
Sleep stage detection agreements between SS and PSG were compared. Within each sleep stage defined by PSG, % of epochs detected by SS as corresponding sleep stages 
were shown. Data are shown as mean ± SE in percentage. In this analysis, 30-s epochs were used to ensure higher resolution comparison.
9
Matsuo et al. Comparisons of Sleep Monitors
Frontiers in Neurology | www.frontiersin.org July 2016 | Volume 7 | Article 110
specificity is more problematic when sleep is more fragmented 
(32). Therefore, the present study assessed both sensitivity and 
specificity to compare performance in addition to correlation 
analysis.
In this study, it was shown that SS and Act80 demonstrated 
good performance with regard to correlation analysis, although 
only SS featured superior performance in sensitivity and 
specificity analysis. The contrast of poor sleep estimation by 
Act40 and Act20 analysis and good sleep estimation by Act80 
suggested a significant effect for the algorithm threshold. 
However, as a result of the high sensitivity to sleep detection, 
Act80 possesses a limited ability to detect wakefulness, espe-
cially when transitions with sleep epochs occur. Although this 
tendency is prominent in Act80, poorer performance rate in 
wake and N1 stage irrespective to methods which is consistent 
with previous reports (33, 34). Therefore, better algorithm that 
can detect the transition between wake and N1 stages should 
be the primary focus for the future development of ambulatory 
sleep recorders. Also, either analysis or data download was 
failed in one of the original 22 participant recordings in both 
MTN and Actiwatch. Although different cause was found for 
each case, mechanical reliability of the device system should 
be improved in the future.
In the current study, SleepScope estimation was the most 
accurate, among all the devices tested. This is evident from the 
high correlation of sleep length estimation and high AUC for 
sleep epoch detection, which was not observed when testing 
activity-based sleep monitors. In addition, unlike activity-
based sleep monitors, EEG-based sleep monitors were able to 
assess sleep architecture, if not fully compatible with PSG. In 
particular, SleepScope uses the channel between forehead and 
mastoid, which is more susceptible to eye movements. This 
choice of electrodes could be advantageous for SleepScope to 
detect REM, which is not readily distinguishable from quiet 
wake by EEG alone. Even with regard to systematic bias (i.e., 
shorter estimation of N3 as well as longer estimation of N2 
and REM), the advantage of EEG-based sleep monitors was 
that the levels of sleep/wake delineation were very similar to 
that obtained using PSG. Since systemic bias was the major 
issue with regard to SleepScope estimation, it is conceivable 
that a slight tuning of the EEG determination algorithm might 
reduce this bias. Since automatic sleep analysis algorithms are 
still under intensive development (17, 19–22), and the detailed 
information of SleepScope algorithm is not available, it is 
expected to develop open-source algorithm with multicenter 
validation.
In brief, EEG-based sleep monitoring should be the preferred 
method for future studies, especially in experiments that require 
measurement of naturalistic sleep quality. While alternatives that 
are more economical are available, activity-based sleep moni-
tors produce less reliable data than single-channel EEG-based 
devices.
To the best of our knowledge, the current study is the first 
report that systemically compares portable devices with differ-
ent modalities, EEG and activity counts, using an EEG oriented 
device, and activity-based sleep monitor, respectively. The effects 
of placement site were also investigated in the present experiment.
The current study features several limitations. Since partici-
pants mostly included university students, these results cannot 
be generalized to a larger more heterogeneous population or 
patient with sleep disorders. Also, caution should be taken in 
interpreting current results, as the participant number of current 
study was relatively small to conclude realistic conclusions. In 
addition, 2-min epochs we used in this study are not conventional 
in sleep research. Thus, it is difficult to directly compare current 
results to previous results, which are based on most conventional 
30-s epochs. Although it might not directly affect inter-method 
comparisons, the so-called “first-night effect” might interfere 
with the current results, since PSG recordings were conducted 
on the first night in the PSG unit for all subjects. Also, in this 
study, a single examiner scored the PSG recordings. Therefore, 
the differences detected might have arisen partly due to the 
examiner’s preference.
In summary, the current study found that the newly developed 
affordable activity-based sleep monitors could be used as a substi-
tute for the current standard Actiwatch. Moreover, single-channel 
EEG-based devices demonstrate superior performance compared 
to activity-based sleep recorders. These findings indicate that 
single-channel EEG-based devices might pose a novel technique 
for the assessment of sleep-related activity in a home-based rather 
than a laboratory setting.
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